🔎 Trials Near Me

Akèy › Adenokasinom Ezofajyen › Distrik Columbia › Washington

Etid klinik pou Adenokasinom Ezofajyen nan Washington, DC

6 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Ap rekriteFaz 2/3
  • MedStar Georgetown University Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Ap rekriteFaz 3
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05677490

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Ap rekriteFaz 2/3
  • Maryland Oncology Hematology, P.A., Silver Spring · 7 mi lwen
  • Maryland Oncology Hematology, P.A., Bethesda · 7 mi lwen
  • Maryland Oncology Hematology, P.A., Largo · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07392892

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Ap rekriteFaz 1
  • Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Ap rekriteFaz 1
  • Normunity Investigational Site, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07182149

Etid Adenokasinom Ezofajyen nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.